CEO’s Insider Buy at Spero Therapeutics Signals Strong Antibacterial Growth PotentialCEO’s RSU purchase shows confidence in Spero Therapeutics’ antibacterial pipeline and upcoming clinical milestones.Spero Therapeutics Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 05/02/2026, 04:00 3 minutes to read